GSA Capital Partners LLP Purchases Shares of 56,264 Trupanion, Inc. $TRUP

GSA Capital Partners LLP purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 56,264 shares of the financial services provider’s stock, valued at approximately $1,394,000. GSA Capital Partners LLP owned about 0.13% of Trupanion at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Millennium Management LLC raised its holdings in Trupanion by 185.8% in the third quarter. Millennium Management LLC now owns 619,003 shares of the financial services provider’s stock valued at $26,790,000 after buying an additional 402,421 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Trupanion by 116.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 477,014 shares of the financial services provider’s stock valued at $17,826,000 after acquiring an additional 256,559 shares during the period. Two Sigma Investments LP lifted its holdings in shares of Trupanion by 3,201.0% during the 3rd quarter. Two Sigma Investments LP now owns 224,433 shares of the financial services provider’s stock valued at $9,713,000 after acquiring an additional 217,634 shares in the last quarter. Polar Capital Holdings Plc lifted its holdings in shares of Trupanion by 13.5% during the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock valued at $55,121,000 after acquiring an additional 175,000 shares in the last quarter. Finally, Marshall Wace LLP boosted its position in Trupanion by 15.5% during the 3rd quarter. Marshall Wace LLP now owns 1,212,151 shares of the financial services provider’s stock worth $52,462,000 after purchasing an additional 163,101 shares during the period.

Insiders Place Their Bets

In other Trupanion news, EVP Steve Weinrauch sold 6,674 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $22.00, for a total transaction of $146,828.00. Following the completion of the sale, the executive vice president owned 78,062 shares in the company, valued at $1,717,364. This trade represents a 7.88% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the sale, the chief executive officer owned 175,401 shares of the company’s stock, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 18,785 shares of company stock valued at $422,862 in the last three months. 5.58% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on TRUP shares. Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Weiss Ratings upgraded Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday. Stifel Nicolaus set a $28.00 target price on Trupanion in a research report on Friday, June 26th. Finally, Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Trupanion has an average rating of “Moderate Buy” and a consensus target price of $41.60.

Trupanion Stock Performance

Trupanion stock opened at $30.60 on Monday. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $49.90. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 57.74, a price-to-earnings-growth ratio of 2.20 and a beta of 1.39. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The firm’s fifty day moving average price is $25.56 and its 200 day moving average price is $26.06.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. The firm had revenue of $392.93 million for the quarter, compared to analyst estimates of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm’s revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.22 EPS. On average, research analysts forecast that Trupanion, Inc. will post 0.59 EPS for the current fiscal year.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.